Cva Family Office, LLC Novartis Ag Transaction History

Cva Family Office, LLC

$606 Million
Q3 2024

A detailed history of Cva Family Office, LLC transactions in Novartis Ag stock. As of the latest transaction made, Cva Family Office, LLC holds 5,722 shares of NVS stock, worth $594,000. This represents 0.11% of its overall portfolio holdings.

Number of Shares

5,722

Previous 5,722 -0.0%

Holding current value

$594,000

Previous $609,000 8.05%

% of portfolio

0.11%

Previous 0.11%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	SELL	$92.57 - $107.37 $15,644 - $18,145	-169 Reduced 2.87%	5,722 $609,000
Q1 2023 Apr 26, 2023	SELL	$80.03 - $92.81 $2,400 - $2,784	-30 Reduced 0.51%	5,891 $541,000
Q4 2022 Feb 21, 2023	BUY	$75.55 - $92.52 $191,141 - $234,075	2,530 Added 74.61%	5,921 $537,000
Q3 2022 Nov 22, 2022	BUY	$74.61 - $87.26 $199,581 - $233,420	2,675 Added 373.6%	3,391 $258,000
Q4 2021 Jan 25, 2022	SELL	$79.7 - $88.13 $43,914 - $48,559	-551 Reduced 43.49%	716 $63,000
Q3 2021 Oct 12, 2021	SELL	$81.78 - $95.14 $6,460 - $7,516	-79 Reduced 5.87%	1,267 $110,000
Q2 2021 Jul 13, 2021	BUY	$85.24 - $94.15 $14,405 - $15,911	169 Added 14.36%	1,346 $123,000
Q1 2021 Apr 14, 2021	SELL	$83.5 - $98.47 $7,515 - $8,862	-90 Reduced 7.1%	1,177 $101,000
Q3 2020 Oct 27, 2020	BUY	$82.14 - $91.0 $3,696 - $4,095	45 Added 3.68%	1,267 $110,000
Q2 2020 Jul 31, 2020	SELL	$80.93 - $91.1 $4,451 - $5,010	-55 Reduced 4.31%	1,222 $107,000
Q1 2020 May 28, 2020	BUY	$70.67 - $99.01 $90,245 - $126,435	1,277 New	1,277 $105,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.

Account

Cva Family Office, LLC Novartis Ag Transaction History